Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Heritage Foods says 'Fresh Paneer' label is descriptive, responds to FSSAI notice
Heritage Foods responded to FSSAI's show-cause notice concerning its 'Fresh Paneer' product label. The company stated the term accurately describes the dairy product's inherent nature. It clarified that 'Fresh Paneer' refers to refrigerated consumption with a limited shelf life. Heritage Foods also addressed the 'Health and Happiness' slogan as a corporate philosophy. The dairy firm reaffirmed its commitment to food safety and regulatory compliance.
Alembic Pharmaceuticals receives USFDA final approval for Dapsone Gel
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Dapsone Gel, 5%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Aczone Gel, 5%, of Almirall, LLC.
Alembic Pharmaceuticals receives USFDA approval for Tretinoin Cream USP, 0.05%
Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Tretinoin Cream USP, 0.05%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Retin-A Cream, 0.05%, of Bausch Health US, LLC. Tretinoin cream is indicated for topical application in the treatment of acne vulgaris.
How Gen Z became the most important customer in FMCG
Young consumers are now driving major decisions at established food companies. Gen-Z and millennials are influencing product development, acquisitions, and marketing strategies. These younger shoppers are health-conscious, digitally savvy, and demand transparency. Their preferences are reshaping the entire packaged foods industry in India.
Alembic Pharmaceuticals receives USFDA tentative approval for Larotrectinib Capsules
Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of Bayer Healthcare Pharmaceuticals Inc. (Bayer).
Food packs still don't tell the full story: Firms make selective label changes as FSSAI rules gather dust
Food companies are now adding voluntary health information to some product labels. These front-of-pack declarations mention sugar, salt, and fat content. This comes as consumers demand more transparency. However, health experts say these limited changes are not enough. Standardized, mandatory labels are needed to truly curb unhealthy food consumption. FSSAI's long-pending regulations remain undecided.
Lupin launches generic anti-diabetic tablets in US
Pharma major Lupin has launched its generic anti-diabetic medicine in the United States. The medicine is dapagliflozin and metformin hydrochloride extended-release tablets. The US Food and Drug Administration approved the drug. Lupin's product is bioequivalent to Xigduo XR. This launch offers a new treatment option for diabetic patients in the US.